Market Overview:
The global biomedical materials market is expected to reach USD XX million by 2030, at a CAGR of XX% during the forecast period 2018-2030. The growth in this market can be attributed to the increasing demand for biomaterials from various application areas such as cardiovascular, orthopedic, ophthalmology and wound healing. In addition, the growing awareness about advanced biomaterials products is also propelling the growth of this market. However, stringent regulatory norms and high cost associated with R&D are some of the factors restraining the growth of this market. Based on type, metallic biomaterials held a dominant share in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to their properties such as biocompatibility and corrosion resistance which make them suitable for use in medical applications.
Product Definition:
Biomedical materials are materials that are used in medical devices and implants. They include metals, plastics, and ceramics. Biomedical materials are important because they can be used to create medical devices and implants that improve patient health.
Metallic Biomaterials:
Metallic biomaterials are materials that have metallic properties for biological systems. They can be used to deliver a wide range of therapeutic and diagnostic agents. Metallic biomaterials offer several advantages over conventional materials such as ease in fabrication, controlled release, and tissue compatibility among others which is expected to drive the market growth during the forecast period.
The global metallic biomaterials market was valued at USD 473 million in 2015.
Ceramics:
Ceramics is a group of solid materials that are made from silica, alumina, and clay. The most common types of ceramics are glass, ceramic tiles, pottery or earthenware vessels (fired), and metal alloys. Ceramic materials have wide applications in the biomedical industry owing to their biocompatibility properties such as low biofouling potential & high surface area which makes them an ideal choice for medical implants & equipment.
Application Insights:
The other application segment includes wound healing, tissue engineering, and cardiovascular applications. The wound healing segment is expected to witness the fastest growth over the forecast period owing to increasing cases of chronic wounds across the globe. According to a study published in 2018 by NCBI, it was estimated that around 15% of diabetic patients suffer from chronic ulcers at any given time. Rising geriatric population and cases of obesity are also contributing towards increased incidence of chronic wounds across the globe. As per data published by WHO in 2017, around 9-12%of global deaths occur due to injuries every year with about 60-80 million people dying due to them every year globally as well as in Europe and North America respectively (based on 2016 data). This is expectedto boost demand for biomedical materials used for treating these typesof injuries during surgeries or accidents resultingin increased product adoption over forecasted periodsto come.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to high healthcare expenditure, availability of skilled professionals, and favorable reimbursement policies & regulatory reforms. Asia Pacific is estimated to be the fastest-growing regional market from 2018 to 2030 due to increasing investments by governments in infrastructure development for medical devices manufacturing and rising awareness about regenerative medicines & therapies. In addition, growing medical tourism industry will drive demand for biocompatible materials over the forecast period.
Moreover, supportive government initiatives such as “Make in India†initiative by encouraging foreign direct investment (FDI) are anticipated favorably impact regional growth over next eight years.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for medical devices is expected to reach 1.9 billion by 2020, growing at a CAGR of 6.5%. This growth can be attributed to the increasing demand for minimally invasive surgeries, which are less risky and cause less pain and scarring than traditional surgery. Biomedical materials are essential components of medical devices, so this growing demand is likely to benefit the biomedical materials market as well.
- Rising prevalence of chronic diseases: The global prevalence of chronic diseases such as cancer, heart disease, and diabetes is rising rapidly due to changing lifestyles and aging populations. This is leading to an increase in the demand for treatments such as chemotherapy, radiation therapy, and surgery, which require biomedical materials.
- Growing investment in R&D: Pharmaceutical companies are investing heavily in R&D in order to develop new drugs and therapies that require biomedical materials for treatment purposes. For example, Johnson & Johnson has announced plans to invest billion in R&D over the next five years with a focus on developing innovative therapies that use biomaterials-based approaches or nanotechnology platforms . This increased investment should benefit the biomedical materials market overall .
Scope Of The Report
Report Attributes
Report Details
Report Title
Biomedical Materials Market Research Report
By Type
Metallic Biomaterials, Ceramics, Polymers, Natural Biomaterials, Other
By Application
Cardiovascular, Orthopedic, Ophthalmology, Wound Healing, Tissue Engineering, Other
By Companies
Royal DSM, BASF, Corbion, Covestro (Subsidiary of Bayer AG), Invibio Ltd. (Subsidiary of Victrex PLC), Carpenter Technology, Roche, Evonik Industries, Berkeley Advanced Biomaterails, Cam Bioceramics, Celanese, Formosa Biomedical Technology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Biomedical Materials Market Report Segments:
The global Biomedical Materials market is segmented on the basis of:
Types
Metallic Biomaterials, Ceramics, Polymers, Natural Biomaterials, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular, Orthopedic, Ophthalmology, Wound Healing, Tissue Engineering, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Royal DSM
- BASF
- Corbion
- Covestro (Subsidiary of Bayer AG)
- Invibio Ltd. (Subsidiary of Victrex PLC)
- Carpenter Technology
- Roche
- Evonik Industries
- Berkeley Advanced Biomaterails
- Cam Bioceramics
- Celanese
- Formosa Biomedical Technology
Highlights of The Biomedical Materials Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Metallic Biomaterials
- Ceramics
- Polymers
- Natural Biomaterials
- Other
- By Application:
- Cardiovascular
- Orthopedic
- Ophthalmology
- Wound Healing
- Tissue Engineering
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biomedical Materials Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biomedical materials are any material that is used in the medical field to help heal or diagnose patients. This can include everything from surgical tools to medications.
Some of the key players operating in the biomedical materials market are Royal DSM, BASF, Corbion, Covestro (Subsidiary of Bayer AG), Invibio Ltd. (Subsidiary of Victrex PLC), Carpenter Technology, Roche, Evonik Industries, Berkeley Advanced Biomaterails, Cam Bioceramics, Celanese, Formosa Biomedical Technology.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Biomedical Materials Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Biomedical Materials Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Biomedical Materials Market - Supply Chain
4.5. Global Biomedical Materials Market Forecast
4.5.1. Biomedical Materials Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Biomedical Materials Market Size (000 Units) and Y-o-Y Growth
4.5.3. Biomedical Materials Market Absolute $ Opportunity
5. Global Biomedical Materials Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Biomedical Materials Market Size and Volume Forecast by Type
5.3.1. Metallic Biomaterials
5.3.2. Ceramics
5.3.3. Polymers
5.3.4. Natural Biomaterials
5.3.5. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Biomedical Materials Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Biomedical Materials Market Size and Volume Forecast by Application
6.3.1. Cardiovascular
6.3.2. Orthopedic
6.3.3. Ophthalmology
6.3.4. Wound Healing
6.3.5. Tissue Engineering
6.3.6. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Biomedical Materials Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Biomedical Materials Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Biomedical Materials Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Biomedical Materials Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Biomedical Materials Demand Share Forecast, 2019-2029
9. North America Biomedical Materials Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Biomedical Materials Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Biomedical Materials Market Size and Volume Forecast by Application
9.4.1. Cardiovascular
9.4.2. Orthopedic
9.4.3. Ophthalmology
9.4.4. Wound Healing
9.4.5. Tissue Engineering
9.4.6. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Biomedical Materials Market Size and Volume Forecast by Type
9.7.1. Metallic Biomaterials
9.7.2. Ceramics
9.7.3. Polymers
9.7.4. Natural Biomaterials
9.7.5. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Biomedical Materials Demand Share Forecast, 2019-2029
10. Latin America Biomedical Materials Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Biomedical Materials Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Biomedical Materials Market Size and Volume Forecast by Application
10.4.1. Cardiovascular
10.4.2. Orthopedic
10.4.3. Ophthalmology
10.4.4. Wound Healing
10.4.5. Tissue Engineering
10.4.6. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Biomedical Materials Market Size and Volume Forecast by Type
10.7.1. Metallic Biomaterials
10.7.2. Ceramics
10.7.3. Polymers
10.7.4. Natural Biomaterials
10.7.5. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Biomedical Materials Demand Share Forecast, 2019-2029
11. Europe Biomedical Materials Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Biomedical Materials Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Biomedical Materials Market Size and Volume Forecast by Application
11.4.1. Cardiovascular
11.4.2. Orthopedic
11.4.3. Ophthalmology
11.4.4. Wound Healing
11.4.5. Tissue Engineering
11.4.6. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Biomedical Materials Market Size and Volume Forecast by Type
11.7.1. Metallic Biomaterials
11.7.2. Ceramics
11.7.3. Polymers
11.7.4. Natural Biomaterials
11.7.5. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Biomedical Materials Demand Share, 2019-2029
12. Asia Pacific Biomedical Materials Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Biomedical Materials Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Biomedical Materials Market Size and Volume Forecast by Application
12.4.1. Cardiovascular
12.4.2. Orthopedic
12.4.3. Ophthalmology
12.4.4. Wound Healing
12.4.5. Tissue Engineering
12.4.6. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Biomedical Materials Market Size and Volume Forecast by Type
12.7.1. Metallic Biomaterials
12.7.2. Ceramics
12.7.3. Polymers
12.7.4. Natural Biomaterials
12.7.5. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Biomedical Materials Demand Share, 2019-2029
13. Middle East & Africa Biomedical Materials Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Biomedical Materials Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Biomedical Materials Market Size and Volume Forecast by Application
13.4.1. Cardiovascular
13.4.2. Orthopedic
13.4.3. Ophthalmology
13.4.4. Wound Healing
13.4.5. Tissue Engineering
13.4.6. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Biomedical Materials Market Size and Volume Forecast by Type
13.7.1. Metallic Biomaterials
13.7.2. Ceramics
13.7.3. Polymers
13.7.4. Natural Biomaterials
13.7.5. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Biomedical Materials Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Biomedical Materials Market: Market Share Analysis
14.2. Biomedical Materials Distributors and Customers
14.3. Biomedical Materials Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Royal DSM
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. BASF
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Corbion
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Covestro (Subsidiary of Bayer AG)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Invibio Ltd. (Subsidiary of Victrex PLC)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Carpenter Technology
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Roche
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Evonik Industries
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Berkeley Advanced Biomaterails
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Cam Bioceramics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Celanese
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Formosa Biomedical Technology
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
